New test guides myeloma treatment choices

NCT ID NCT02911571

First seen May 09, 2026 · Last updated May 21, 2026 · Updated 2 times

Summary

This study looks at whether a test called MMprofiler helps doctors decide on the best treatment for people with multiple myeloma, a type of blood cancer. About 250 patients who are about to start treatment will take part. The main goal is to see if the test changes what treatment the doctor chooses.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Columbia University Medical Center

    New York, New York, 10032, United States

  • Hackensack University Medical Center

    Hackensack, New Jersey, 07601, United States

  • Levine Cancer Institute

    Charlotte, North Carolina, 28204, United States

  • Lombardi Comprehensive Cancer Center

    Washington D.C., District of Columbia, 20007, United States

  • Medical College of Wisconsin

    Milwaukee, Wisconsin, 53226, United States

  • New York Presbyterian Brooklyn Methodist Hospital

    Brooklyn, New York, 11215, United States

  • Wake Forest Baptist Medical Center,

    Winston-Salem, North Carolina, 27157, United States

  • Weill Cornell Medicine

    New York, New York, 10065, United States

  • Winship Cancer Institute, Emory University

    Atlanta, Georgia, 30322, United States

Conditions

Explore the condition pages connected to this study.